Inter-ictal and post-ictal circulating levels of allopregnanolone, an anticonvulsant metabolite of progesterone, in epileptic children

Epilepsy Research

Volumn 54, Issue 1, 2003, Pages 29-34

  Grosso, Salvatore ^a   Luisi, Stefano ^a   Mostardini, Rosa ^a   Farnetani, MariAngela ^a   Cobellis, Luigi ^a   Morgese, Guido ^a   Balestri, Paolo ^a   Petraglia, Felice ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Allopregnanolone; Epilepsy; Neuroactive steroids; Neurosteroids

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; PROGESTERONE;

ARTICLE; CHILD; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; FEMALE; FRONTAL LOBE EPILEPSY; HORMONE BLOOD LEVEL; HUMAN; INFANT; INFANTILE SPASM; MAJOR CLINICAL STUDY; MALE; MYOCLONUS SEIZURE; OCCIPITAL LOBE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SEIZURE; TEMPORAL LOBE EPILEPSY; TONIC SEIZURE;

EID: 0038397543     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(03)00042-1     Document Type: Article

References (31)

1. Akwa Y., Young J., Kabbadj K., Sancho M.J., Zucman D., Vourc'h C., Jung-Testas I., Hu Z.Y., Le Goascogne C., Jo D.H. Neurosteroids: biosynthesis, metabolism and function of pregnenolone and dehydroepiandrosterone in the brain. J. Steroid Biochem. Mol. Biol. 40:1991;71-81.
2. Belelli D., Bolger M.B., Gee K.W. Anticonvulsant profile of the progesterone metabolite 5 alpha-pregnan-3 alpha-ol-20-one. Eur. J. Pharmacol. 166:1989;325-329.
3. Belelli D., Lan N.C., Gee K.W. Anticonvulsant steroids and the GABA/benzodiazepine receptor-chloride ionophore complex. Neurosci. Biobehav. Rev. 14:1990;315-322.
4. Bixo M., Andersson A., Winblad B., Purdy R.H., Backstrom T. Progesterone, 5alpha-pregnane-3,20-dione and 3alpha-hydroxy-5alpha-pregnane-20-one in specific regions of the human female brain in different endocrine states. Brain Res. 764:1997;173-178.
5. Brinton R.D. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one induces cytoarchitectural regression in cultured fetal hippocampal neurons. J. Neurosci. 14:1994;2763-2774.
6. Commission on classification and terminology of the International League Against Epilepsy, 1981. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22, 489-501.
7. Commission on classification and terminology of the International League Against Epilepsy, 1989. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30, 389-399.
8. Corpechot C., Young J., Calvel M., Wehrey C., Veltz J.N., Touyer G., Mouren M., Prasad V.V., Banner C., Sjovall J. Neurosteroids: 3 alpha-hydroxy-5 alpha-pregnan-20-one and its precursors in the brain plasma and steroidogenic glands of male and female rats. Endocrinology. 133:1993;1003-1009.
9. Czlonkowska A.I., Krzascik P., Sienkiewicz-Jarosz H., Siemiatkowski M., Szyndler J., Bidzinski A., Plaznik A. The effects of neurosteroids on picrotoxin-, bicuculline- and NMDA-induced seizures, and a hypnotic effect of ethanol. Pharmacol. Biochem. Behav. 67:2000;345-353.
10. Fadalti M., Petraglia F., Luisi S., Bernardi F., Casarosa E., Ferrari E., Luisi M., Saggese G., Genazzani A.R., Bernasconi S. Changes of serum allopregnanolone levels in the first 2 years of life and during pubertal development. Pediatr. Res. 46:1999;323-327.
11. Finn D.A., Roberts A.J., Crabbe J.C. Neuroactive steroid sensitivity in withdrawal seizure-prone and -resistant mice. Alcohol Clin. Exp. Res. 19:1995;410-415.
12. Frye C.A. The neurosteroid 3 alpha, 5 apha-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res. 696:1995;113-120.
13. Frye C.A., Manjarrez J., Camacho-Arroyo I. Infusion of 3alpha,5alpha-THP to the pontine reticular formation attenuates PTZ-induced seizures. Brain Res. 881:2000;98-102.
14. Frye C.A., Muscatiello N.A. 3alpha,5alpha-THP in the raphe magnus attenuates PTZ-induced myoclonic seizures. Brain Res. 911:2001;146-151.
15. Frye C.A., Scalise T.J. Anti-seizure effects of progesterone and 3alpha,5alpha-THP in kainic acid and perforant pathway models of epilepsy. Psychoneuroendocrinology. 25:2000;407-420.
16. Galli R., Luisi M., Pizzanelli C., Monteleone P., Casarosa E., Iudice A., Murri L. Circulating levels of allopregnanolone, an anticonvulsant metabolite of progesterone, in women with partial epilepsy in the postcritical phase. Epilepsia. 42:2001;216-219.
17. Gasior M., Carter R.B., Witkin J.M. Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders. Trends Pharmacol. Sci. 20:1999;107-112.
18. Genazzani A.R., Petraglia F., Bernardi F., Casarosa E., Salvestroni C., Tonetti A., Nappi R.E., Luisi S., Palumbo M., Purdy R.H., Luisi M. Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences. J. Clin. Endocrinol. Metab. 83:1998;2099-2103.
19. Jung-Testas I., Hu Z.Y., Baulieu E.E., Robel P. Neurosteroids: biosynthesis of pregnenolone and progesterone in primary cultures of rat glial cells. Endocrinology. 125:1989;2083-2091.
20. Kerrigan J.F., Shields W.D., Nelson T.Y., Bluestone D.L., Dodson W.E., Bourgeois B.F., Pellock J.M., Morton L.D., Monaghan E.P. Ganaxolone for treating intractable infantile spasms: a multicenter, open-label, add-on trial. Epilepsy Res. 42:2000;133-139.
21. Lambert J.J., Belelli D., Hill-Venning C., Peters J.A. Neurosteroids and GABA(A) receptor function. Trends Pharmacol. Sci. 16:1995;295-303.
22. Maciejak P., Krzascik P., Czlonkowska A.I., Szyndler J., Bidzinski A., Walkowiak J., Kostowski W., Plaznik A. Antagonism of picrotoxin-induced changes in dopamine and serotonin metabolism by allopregnanolone and midazolam. Pharmacol. Biochem. Behav. 72:2002;987-991.
23. Mellon S.H., Vaudry H. Biosynthesis of neurosteroids and regulation of their synthesis. Int. Rev. Neurobiol. 46:2001;33-78.
24. Mtchedlishvili Z., Bertram E.H., Kapur J. Diminished allopregnanolone enhancement of GABA(A) receptor currents in a rat model of chronic temporal lobe epilepsy. J. Physiol. 537:2001;453-465.
25. Patchev V.K., Shoaib M., Holsboer F., Almeida O.F. The neurosteroid: tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus. Neuroscience. 62:1994;265-271.
26. Paul S.M., Purdy R.H. Neuroactive steroids. FASEB J. 6:1992;2311-2322.
27. Purdy R.H., Morrow A.L., Blinn J.R., Paul S.M. Synthesis, metabolism, and pharmacological activity of 3 alpha-hydroxy steroids which potentiate GABA-receptor-mediated chloride ion uptake in rat cerebral cortical synaptoneurosomes. J. Med. Chem. 33:1990a;1572-1581.
28. Purdy R.H., Moore P.H. Jr., Rao P.N., Hagino N., Yamaguchi T., Schmidt P., Rubinow D.R., Morrow A.L., Paul S.M. Radioimmunoassay of 3 alpha-hydroxy-5 alpha-pregnan-20-one in rat and human plasma. Steroids. 55:1990b;290-296.
29. Purdy R.H., Morrow A.L., Moore P.H. Jr., Paul S.M. Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain. Proc. Natl. Acad. Sci. USA. 88:1991;4553-4557.
30. Reddy D.S., Kim H.Y., Rogawski M.A. Neurosteroid withdrawal model of perimenstrual catamenial epilepsy. Epilepsia. 42:2001;328-336.
31. Reddy D.S., Rogawski M.A. Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy. Epilepsia. 42:2001;337-344.